Federal Judge Orders Halt to USAID Work Stoppage; New CDC Data Reflects Silent Avian Flu Spread 14/02/2025 Elaine Ruth Fletcher A coalition of American non-profit, legal and small business groups welcomed a federal judge’s temporary restraining order (TRO) halting the Trump Administration’s executive order freezing virtually all USAID activities – followed by a “stop work” order on the agency by new US Secretary of State Marco Rubio. The ruling Thursday evening in a Washington DC […] Continue reading -> US Funding Freeze Hits Mpox Response in DRC; Ebola Trial Progresses in Uganda 13/02/2025 Paul Adepoju As Africa battles a relentless mpox outbreak, a sudden freeze in United States foreign aid is crippling containment efforts, threatening vaccine distribution, and leaving the hardest-hit regions scrambling for solutions, the Africa Centres for Disease Control and Prevention (Africa CDC) warned on Thursday. In conflict-ridden Democratic Republic of Congo (DRC), the epicentre of the outbreak, […] Continue reading -> Campaign Aims to Expose Big Soda’s ‘Sportswashing;’ Petition Captures 255,000 Signatures 25/11/2024 Editorial team The “Kick Big Soda Out!” campaign launched on July 8, 2024 ahead of the 2024 Paris Olympics and ran through the end of the Paralympics. It’s all about holding sugary drinks companies – especially Coca-Cola – accountable for their impact on health and the environment. To discuss the campaign, Health Policy Watch spoke to Trish […] Continue reading -> Post Pandemic: Wastewater-based Surveillance of Diseases Comes of Age 22/11/2024 Elaine Ruth Fletcher A method that first developed around polio elimination and matured during the COVID pandemic, is now being tested and used to track a much wider array of emerging disease threats. A unique symposium of scientists and public health experts at the Paris Sorbonne University last week looked at its promise and potential. In April 2020, […] Continue reading -> WHO Hits Halfway Mark in Budget ‘Ask’ After $1.7 Billion in New Pledges at G20 Summit 22/11/2024 Disha Shetty The World Health Organization (WHO) received $1.7 billion in new pledges of financial support at the G20 meeting this week, taking the total of voluntary pledges so far to $3.8 billion for the coming four years. With this, the WHO has met 53% of its investment requirement for its 2025–2028 strategy, in WHO parlance, the 14th […] Continue reading -> Gavi Includes Ebola, Meningitis, Rabies and Hepatitis B Vaccines in its Portfolio 24/06/2024 Zuzanna Stawiska Gavi, the Vaccine Alliance, announced last week that it will offer high risk countries the option of obtaining preventative Ebola vaccines, particularly for health workers, as part of the rollout of new vaccine offerings, which also include meningitis, rabies and hepatitis B vaccines. Plans to add the vaccines to the basket of available products were […] Continue reading -> Global Pandemic Preparedness Report Reveals Lack of Investment in Therapeutics and Vaccines 24/01/2024 Maayan Hoffman There is a global lack of preparedness and reactive responses when confronted with emerging epidemic threats, a concerning lack of investment in the R&D vaccine and therapeutics pipeline, and signs of waning focus on pandemic preparedness, according to a new report by the International Pandemic Preparedness Secretariat (IPPS). The IPPS launched its third annual report on […] Continue reading -> Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> New WHO and UN-wide System to Aid Victims of Sexual Exploitation Needed, says Independent Investigator 07/07/2023 Stefan Anderson The World Health Organiztion (WHO) has been far too slow in providing financial, psychological and legal assistance to victims of sexual assault and exploitation committed by its staff in the Democratic Republic of Congo (DRC) during the 2018-2020 Ebola response, a veteran international investigator said at a WHO press conference on Friday. Hervé Gogo, presenting […] Continue reading -> Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
US Funding Freeze Hits Mpox Response in DRC; Ebola Trial Progresses in Uganda 13/02/2025 Paul Adepoju As Africa battles a relentless mpox outbreak, a sudden freeze in United States foreign aid is crippling containment efforts, threatening vaccine distribution, and leaving the hardest-hit regions scrambling for solutions, the Africa Centres for Disease Control and Prevention (Africa CDC) warned on Thursday. In conflict-ridden Democratic Republic of Congo (DRC), the epicentre of the outbreak, […] Continue reading -> Campaign Aims to Expose Big Soda’s ‘Sportswashing;’ Petition Captures 255,000 Signatures 25/11/2024 Editorial team The “Kick Big Soda Out!” campaign launched on July 8, 2024 ahead of the 2024 Paris Olympics and ran through the end of the Paralympics. It’s all about holding sugary drinks companies – especially Coca-Cola – accountable for their impact on health and the environment. To discuss the campaign, Health Policy Watch spoke to Trish […] Continue reading -> Post Pandemic: Wastewater-based Surveillance of Diseases Comes of Age 22/11/2024 Elaine Ruth Fletcher A method that first developed around polio elimination and matured during the COVID pandemic, is now being tested and used to track a much wider array of emerging disease threats. A unique symposium of scientists and public health experts at the Paris Sorbonne University last week looked at its promise and potential. In April 2020, […] Continue reading -> WHO Hits Halfway Mark in Budget ‘Ask’ After $1.7 Billion in New Pledges at G20 Summit 22/11/2024 Disha Shetty The World Health Organization (WHO) received $1.7 billion in new pledges of financial support at the G20 meeting this week, taking the total of voluntary pledges so far to $3.8 billion for the coming four years. With this, the WHO has met 53% of its investment requirement for its 2025–2028 strategy, in WHO parlance, the 14th […] Continue reading -> Gavi Includes Ebola, Meningitis, Rabies and Hepatitis B Vaccines in its Portfolio 24/06/2024 Zuzanna Stawiska Gavi, the Vaccine Alliance, announced last week that it will offer high risk countries the option of obtaining preventative Ebola vaccines, particularly for health workers, as part of the rollout of new vaccine offerings, which also include meningitis, rabies and hepatitis B vaccines. Plans to add the vaccines to the basket of available products were […] Continue reading -> Global Pandemic Preparedness Report Reveals Lack of Investment in Therapeutics and Vaccines 24/01/2024 Maayan Hoffman There is a global lack of preparedness and reactive responses when confronted with emerging epidemic threats, a concerning lack of investment in the R&D vaccine and therapeutics pipeline, and signs of waning focus on pandemic preparedness, according to a new report by the International Pandemic Preparedness Secretariat (IPPS). The IPPS launched its third annual report on […] Continue reading -> Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> New WHO and UN-wide System to Aid Victims of Sexual Exploitation Needed, says Independent Investigator 07/07/2023 Stefan Anderson The World Health Organiztion (WHO) has been far too slow in providing financial, psychological and legal assistance to victims of sexual assault and exploitation committed by its staff in the Democratic Republic of Congo (DRC) during the 2018-2020 Ebola response, a veteran international investigator said at a WHO press conference on Friday. Hervé Gogo, presenting […] Continue reading -> Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Campaign Aims to Expose Big Soda’s ‘Sportswashing;’ Petition Captures 255,000 Signatures 25/11/2024 Editorial team The “Kick Big Soda Out!” campaign launched on July 8, 2024 ahead of the 2024 Paris Olympics and ran through the end of the Paralympics. It’s all about holding sugary drinks companies – especially Coca-Cola – accountable for their impact on health and the environment. To discuss the campaign, Health Policy Watch spoke to Trish […] Continue reading -> Post Pandemic: Wastewater-based Surveillance of Diseases Comes of Age 22/11/2024 Elaine Ruth Fletcher A method that first developed around polio elimination and matured during the COVID pandemic, is now being tested and used to track a much wider array of emerging disease threats. A unique symposium of scientists and public health experts at the Paris Sorbonne University last week looked at its promise and potential. In April 2020, […] Continue reading -> WHO Hits Halfway Mark in Budget ‘Ask’ After $1.7 Billion in New Pledges at G20 Summit 22/11/2024 Disha Shetty The World Health Organization (WHO) received $1.7 billion in new pledges of financial support at the G20 meeting this week, taking the total of voluntary pledges so far to $3.8 billion for the coming four years. With this, the WHO has met 53% of its investment requirement for its 2025–2028 strategy, in WHO parlance, the 14th […] Continue reading -> Gavi Includes Ebola, Meningitis, Rabies and Hepatitis B Vaccines in its Portfolio 24/06/2024 Zuzanna Stawiska Gavi, the Vaccine Alliance, announced last week that it will offer high risk countries the option of obtaining preventative Ebola vaccines, particularly for health workers, as part of the rollout of new vaccine offerings, which also include meningitis, rabies and hepatitis B vaccines. Plans to add the vaccines to the basket of available products were […] Continue reading -> Global Pandemic Preparedness Report Reveals Lack of Investment in Therapeutics and Vaccines 24/01/2024 Maayan Hoffman There is a global lack of preparedness and reactive responses when confronted with emerging epidemic threats, a concerning lack of investment in the R&D vaccine and therapeutics pipeline, and signs of waning focus on pandemic preparedness, according to a new report by the International Pandemic Preparedness Secretariat (IPPS). The IPPS launched its third annual report on […] Continue reading -> Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> New WHO and UN-wide System to Aid Victims of Sexual Exploitation Needed, says Independent Investigator 07/07/2023 Stefan Anderson The World Health Organiztion (WHO) has been far too slow in providing financial, psychological and legal assistance to victims of sexual assault and exploitation committed by its staff in the Democratic Republic of Congo (DRC) during the 2018-2020 Ebola response, a veteran international investigator said at a WHO press conference on Friday. Hervé Gogo, presenting […] Continue reading -> Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Post Pandemic: Wastewater-based Surveillance of Diseases Comes of Age 22/11/2024 Elaine Ruth Fletcher A method that first developed around polio elimination and matured during the COVID pandemic, is now being tested and used to track a much wider array of emerging disease threats. A unique symposium of scientists and public health experts at the Paris Sorbonne University last week looked at its promise and potential. In April 2020, […] Continue reading -> WHO Hits Halfway Mark in Budget ‘Ask’ After $1.7 Billion in New Pledges at G20 Summit 22/11/2024 Disha Shetty The World Health Organization (WHO) received $1.7 billion in new pledges of financial support at the G20 meeting this week, taking the total of voluntary pledges so far to $3.8 billion for the coming four years. With this, the WHO has met 53% of its investment requirement for its 2025–2028 strategy, in WHO parlance, the 14th […] Continue reading -> Gavi Includes Ebola, Meningitis, Rabies and Hepatitis B Vaccines in its Portfolio 24/06/2024 Zuzanna Stawiska Gavi, the Vaccine Alliance, announced last week that it will offer high risk countries the option of obtaining preventative Ebola vaccines, particularly for health workers, as part of the rollout of new vaccine offerings, which also include meningitis, rabies and hepatitis B vaccines. Plans to add the vaccines to the basket of available products were […] Continue reading -> Global Pandemic Preparedness Report Reveals Lack of Investment in Therapeutics and Vaccines 24/01/2024 Maayan Hoffman There is a global lack of preparedness and reactive responses when confronted with emerging epidemic threats, a concerning lack of investment in the R&D vaccine and therapeutics pipeline, and signs of waning focus on pandemic preparedness, according to a new report by the International Pandemic Preparedness Secretariat (IPPS). The IPPS launched its third annual report on […] Continue reading -> Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> New WHO and UN-wide System to Aid Victims of Sexual Exploitation Needed, says Independent Investigator 07/07/2023 Stefan Anderson The World Health Organiztion (WHO) has been far too slow in providing financial, psychological and legal assistance to victims of sexual assault and exploitation committed by its staff in the Democratic Republic of Congo (DRC) during the 2018-2020 Ebola response, a veteran international investigator said at a WHO press conference on Friday. Hervé Gogo, presenting […] Continue reading -> Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
WHO Hits Halfway Mark in Budget ‘Ask’ After $1.7 Billion in New Pledges at G20 Summit 22/11/2024 Disha Shetty The World Health Organization (WHO) received $1.7 billion in new pledges of financial support at the G20 meeting this week, taking the total of voluntary pledges so far to $3.8 billion for the coming four years. With this, the WHO has met 53% of its investment requirement for its 2025–2028 strategy, in WHO parlance, the 14th […] Continue reading -> Gavi Includes Ebola, Meningitis, Rabies and Hepatitis B Vaccines in its Portfolio 24/06/2024 Zuzanna Stawiska Gavi, the Vaccine Alliance, announced last week that it will offer high risk countries the option of obtaining preventative Ebola vaccines, particularly for health workers, as part of the rollout of new vaccine offerings, which also include meningitis, rabies and hepatitis B vaccines. Plans to add the vaccines to the basket of available products were […] Continue reading -> Global Pandemic Preparedness Report Reveals Lack of Investment in Therapeutics and Vaccines 24/01/2024 Maayan Hoffman There is a global lack of preparedness and reactive responses when confronted with emerging epidemic threats, a concerning lack of investment in the R&D vaccine and therapeutics pipeline, and signs of waning focus on pandemic preparedness, according to a new report by the International Pandemic Preparedness Secretariat (IPPS). The IPPS launched its third annual report on […] Continue reading -> Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> New WHO and UN-wide System to Aid Victims of Sexual Exploitation Needed, says Independent Investigator 07/07/2023 Stefan Anderson The World Health Organiztion (WHO) has been far too slow in providing financial, psychological and legal assistance to victims of sexual assault and exploitation committed by its staff in the Democratic Republic of Congo (DRC) during the 2018-2020 Ebola response, a veteran international investigator said at a WHO press conference on Friday. Hervé Gogo, presenting […] Continue reading -> Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Gavi Includes Ebola, Meningitis, Rabies and Hepatitis B Vaccines in its Portfolio 24/06/2024 Zuzanna Stawiska Gavi, the Vaccine Alliance, announced last week that it will offer high risk countries the option of obtaining preventative Ebola vaccines, particularly for health workers, as part of the rollout of new vaccine offerings, which also include meningitis, rabies and hepatitis B vaccines. Plans to add the vaccines to the basket of available products were […] Continue reading -> Global Pandemic Preparedness Report Reveals Lack of Investment in Therapeutics and Vaccines 24/01/2024 Maayan Hoffman There is a global lack of preparedness and reactive responses when confronted with emerging epidemic threats, a concerning lack of investment in the R&D vaccine and therapeutics pipeline, and signs of waning focus on pandemic preparedness, according to a new report by the International Pandemic Preparedness Secretariat (IPPS). The IPPS launched its third annual report on […] Continue reading -> Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> New WHO and UN-wide System to Aid Victims of Sexual Exploitation Needed, says Independent Investigator 07/07/2023 Stefan Anderson The World Health Organiztion (WHO) has been far too slow in providing financial, psychological and legal assistance to victims of sexual assault and exploitation committed by its staff in the Democratic Republic of Congo (DRC) during the 2018-2020 Ebola response, a veteran international investigator said at a WHO press conference on Friday. Hervé Gogo, presenting […] Continue reading -> Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Global Pandemic Preparedness Report Reveals Lack of Investment in Therapeutics and Vaccines 24/01/2024 Maayan Hoffman There is a global lack of preparedness and reactive responses when confronted with emerging epidemic threats, a concerning lack of investment in the R&D vaccine and therapeutics pipeline, and signs of waning focus on pandemic preparedness, according to a new report by the International Pandemic Preparedness Secretariat (IPPS). The IPPS launched its third annual report on […] Continue reading -> Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> New WHO and UN-wide System to Aid Victims of Sexual Exploitation Needed, says Independent Investigator 07/07/2023 Stefan Anderson The World Health Organiztion (WHO) has been far too slow in providing financial, psychological and legal assistance to victims of sexual assault and exploitation committed by its staff in the Democratic Republic of Congo (DRC) during the 2018-2020 Ebola response, a veteran international investigator said at a WHO press conference on Friday. Hervé Gogo, presenting […] Continue reading -> Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
Some Cancer Drugs Excluded from New WHO Essential Medicines List Because of Cost 26/07/2023 Kerry Cullinan High cost has prevented some cancer drugs from being included in the World Health Organization’s (WHO) updated Essential Medicines List (EML) and Essential Medicines for List Children (EMLc) released on Wednesday. These include “patented, highly-priced” treatments for lung and breast cancer. “With the cancer medicines, we are facing now an issue where we have a […] Continue reading -> New WHO and UN-wide System to Aid Victims of Sexual Exploitation Needed, says Independent Investigator 07/07/2023 Stefan Anderson The World Health Organiztion (WHO) has been far too slow in providing financial, psychological and legal assistance to victims of sexual assault and exploitation committed by its staff in the Democratic Republic of Congo (DRC) during the 2018-2020 Ebola response, a veteran international investigator said at a WHO press conference on Friday. Hervé Gogo, presenting […] Continue reading -> Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy Loading Comments... You must be logged in to post a comment.
New WHO and UN-wide System to Aid Victims of Sexual Exploitation Needed, says Independent Investigator 07/07/2023 Stefan Anderson The World Health Organiztion (WHO) has been far too slow in providing financial, psychological and legal assistance to victims of sexual assault and exploitation committed by its staff in the Democratic Republic of Congo (DRC) during the 2018-2020 Ebola response, a veteran international investigator said at a WHO press conference on Friday. Hervé Gogo, presenting […] Continue reading -> Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> Posts navigation Older posts This site uses cookies to help give you the best experience on our website. Cookies enable us to collect information that helps us personalise your experience and improve the functionality and performance of our site. By continuing to read our website, we assume you agree to this, otherwise you can adjust your browser settings. Please read our cookie and Privacy Policy. Our Cookies and Privacy Policy
Marburg, Ebola Sudan Vaccines Might Get Share of COVAX Surplus 04/07/2023 Megha Kaveri Some of the $2.6 billion that remains in a COVID-19 vaccine delivery scheme, COVAX, could be redirected into investment into investigational vaccine candidates for Marburg Virus Disease (MVD) and Ebola Sudan strain virus, as well as over half a dozen other vaccine programmes that were suspended due to the pandemic or delays in product development, […] Continue reading -> Posts navigation Older posts